CRP and IL-6 are acute-phase reactants elevated during systemic inflammation and platelet activation, whereas TNF-α is involved in promoting endothelial dysfunction, leukocyte adhesion, and vascular inflammation. The gene discussed is IL6; the disease is endothelial dysfunction.